We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Novel Antisense Drug Could Help Slow Fatty Liver Disease

News   Jun 17, 2020 | Original story from University of California San Diego

 
Novel Antisense Drug Could Help Slow Fatty Liver Disease

Non-alcoholic fatty liver disease. Credit: 2009 Michael Bonert. CC BY-SA 3.0.

 
 
Advertisement
 

RELATED ARTICLES

How Bacteria in Cystic Fibrosis Patients Overcome Treatments

News

Researchers have discovered a slimy strategy used by bacteria to defeat antibiotics and other drugs used to combat infections afflicting people with cystic fibrosis.

READ MORE

Janssen COVID-19 Vaccine Issued Emergency Use Authorization by the FDA

News

The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S or JNJ-78436725.

READ MORE

Neanderthal Protein May Reduce the Severity of COVID-19

News

Researchers at the Lady Davis Institute (LDI) at the Jewish General Hospital have discovered that increased levels of the protein OAS1 are associated with reduced mortality and less severe disease requiring ventilation among patients with COVID-19. Using drugs that boost OAS1 levels could be explored to try to improve these outcomes.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE